date/time interval
- April 1, 2021 - March 31, 2025
Investigation of UBR5 and its signaling as a novel target for breast cancer therapy
Grant
Overview
awarded by
administered by
sponsor award ID
- W81XWH2110261
Affiliation
contributor
- Ma, Xiaojing Principal Investigator 2021 - 2024
- Xu, Aizhang Key Personnel 2021 - 2024